Form EFFECT CNS Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 13, 2025 9:30 A.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Audrey Saylor Scholarship for Manufacturing Announces One-Time Award to Support Future Industry Leaders in South Dakota and Beyond
- Dr. Wade Newman Launches Scholarship for Future Doctors to Support Undergraduate Pre-Med Students Nationwide in 2027
- Kevin Sumlin Announces 2026 Recipient of the Kevin Sumlin Scholarship for Student Athletes
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
